Over the past six months, DexCom has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $91.17, representing a healthy 23.6% incr…
Updated Sep 1, 2026
Upgrade to a paid plan to see AI rating history on the chart.
Over the past six months, DexCom has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $91.17, representing a healthy 23.6% incr…
SAN DIEGO, September 01, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Wells Fargo 21st Annual…
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Great stock picks are just the start to building a portfolio that can shelter you through whatever the market brings.
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOQ3ZjaFU3M3dEV2dEcXZ2NHBzNm9hM2NTb3ZwTVhRY3JvaWlMV29NMmU2X18wbHlIbzNmOU1PTzB0RFoxXzdNTU9ZNU51cTFtT…
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOdjkxSkJKZWl2QmVzMXpJUXlaeUh0ZHJJdHZPZ0Fkek9CNXBMVjNITlE5V1J1dEUtRXFzZXFrbzF0S2NsbGxqWnlNNHBtb2pCc…
Abbott just scored a regulatory first in diabetes care that no rival has matched, yet the stock sits well below where it traded a year ago. The real question i…
Dexcom CEO Jake Leach said he is watching for a decision by the federal health insurance program before the end of the year.
Not investment advice. Past performance does not guarantee future results. Full disclaimer